Safety and efficacy of immune checkpoint inhibitors in advanced penile cancer: report from the Global Society of Rare Genitourinary Tumors is a research paper published in JNCI Journal of the National Cancer Institute (2023). On theSindex it has a DataRank of 0.609. It has been cited 57 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.609
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NCI NIH HHS
Grant: T32 CA247815
NCI NIH HHS
Grant: UG1 CA233328
NIAID NIH HHS
Grant: K01 AI163412
NCATS NIH HHS
Grant: UL1 TR004419
National Institutes of Health
Grant: 2P50CA101942-16
DF/HCC Kidney Cancer SPORE
National Institutes of Health
Grant: 5P30CA006516-56
Dana-Farber/Harvard Cancer Center
NIH
FWCI
14.46
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals